In an effort to expand its gastroenterology portfolio, Allergan plans to acquire Tobira Therapeutics for up to $1.69 billion.
The FDA approved STELARA, a Crohn’s disease treatment developed by Janssen Biotech.
Boston Scientific is the leading competitor in the GI/endoscopic device market, followed by Olympus.
The Israeli medical device company MOTUS GI received FDA clearance for its Pure-Vu System.
Cantel Medical acquired endoscope reprocessing business assets from Vantage Endoscopy.
Surgical Endoscopy published the results of a three-year controlled trial concerning long-term chronic gastroesophageal reflux disease control after a transoral incisionless fundoplication procedure with EsophyX, a device developed by EndoGastric Solutions.
Takeda Pharmaceutical was named one of Working Mother magazine’s “Working Mother 100 Best Companies.”
More articles on gastroenterology and endoscopy:
GI societies objects to American Board of Internal Medicine’s certification proposals: 4 notes
FDA clears Pure-Vu System for intra-procedural colon cleaning: 3 notes
Takeda named in Working Mother’s top companies: 3 notes
